Kiora Pharmaceuticals Announced Private Placement Of Up To ~$45M
Author: Charles Gross | January 31, 2024 07:43pm
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics to improve sight in patients with severe vision loss due to inherited or age-related orphan retinal diseases, today announced that it has entered into a securities purchase agreement with healthcare focused institutional investor(s) to raise up to approximately $45 million in gross proceeds, including initial upfront funding of $15 million and up to an additional approximately $30 million upon exercise of accompanying warrants at the election of the investors.
Posted In: KPRX